Diabetes mellitus (DM) and cardiovascular complications are two unmet medical
emergencies that can occur together. The rising incidence of heart failure in diabetic …

Cardiovascular diseases have become a major clinical burden globally. Heart failure is one
of the diseases that commonly emanates from progressive uncontrolled hypertension. This …

Background Cardiac fibrosis represents a key element in the pathophysiology of heart
failure with preserved ejection fraction (HFpEF), a condition highly prevalent amongst …

Heart failure (HF) with preserved ejection fraction (HFpEF) is currently a preeminent
challenge for cardiovascular medicine. It has a poor prognosis, increasing mortality, and is …

Heart failure is one of the main causes of morbidity and mortality around the globe. Heart
failure with preserved ejection fraction is primarily caused by diastolic dysfunction. Adipose …

Simple Summary Anthracycline-induced cardiotoxicity (AIC) poses a significant clinical
challenge in the management of cancer patients. Thus, the development of effective …

Angiotensin receptor–neprilysin inhibitors have multiple beneficial effects on the
cardiovascular system. The angiotensin receptor–neprilysin inhibitor sacubitril/valsartan has …

Obesity condition causes morphological and functional alterations involving the
cardiovascular system. These can represent the substrates for different cardiovascular …

Heart failure with preserved ejection fraction (HFpEF) represents a multifaceted syndrome
related to complex pathologic mechanisms. Sacubitril/valsartan (Sac/val) has demonstrated …

Cardiovascular diseases are the leading cause of mortality in the world. Heart failure with
preserved ejection fraction (HFpEF) accounts for about half of all heart failure. Unfortunately …